Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.58 |
| ▸ | LPL | P06858 | 3/20 | 0.58 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | MGLL | Q99685 | 2/20 | 0.54 |
| ▸ | RXRA | P19793 | 2/20 | 0.50 |
| ▸ | RXRB | P28702 | 2/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.41 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.41 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.41 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1853563 | 0.83 | CA2 (0.84) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL806612 | 0.83 | CA2 (0.67) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL2700407 | 0.81 | MGLL (0.59) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL13667445 | 0.80 | CA2 (0.78) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL18394607 | 0.80 | CA2 (0.78) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL806835 | 0.80 | CA2 (0.78) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL13284207 | 0.79 | MGLL (0.57) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL13284206 | 0.79 | MGLL (0.57) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL24172378 | 0.78 | CA2 (0.54) | CA2LPLLIPGCA1MGLL | |
| SCHEMBL2556210 | 0.78 | CA2 (0.48) | CA2LPLLIPGCA1MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3105202-B1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2024-11-13 | — | — | EP | disclosed |
| CN-106103392-B | Graphene nanoribbons with controlled zig-zag edge and curved edge configurations | 巴斯夫欧洲公司 | 2020-06-26 | — | — | CN | disclosed |
| US-10329378-B2 | Graphene nanoribbons with controlled zig-zag edge and cove edge configuration | BASF SE (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170051101-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2017-02-23 | — | — | US | disclosed |
| US-20170051101-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2017-02-23 | — | — | US | disclosed |
| US-20170051101-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2017-02-23 | — | — | US | disclosed |
| EP-3105202-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2016-12-21 | — | — | EP | disclosed |
| WO-2015121785-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2015-08-20 | — | — | WO | disclosed |
| EP-2907791-A1 | Graphene nanoribbons with controlled zig-zag edge and cove edge configuration | BASF SE (DE) | 2015-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170051101-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | ZC3HAV1L, ZC3HAV1, ZYX | CA2 4550/4885LPL 2282/4885LIPG 55/4885 |
| US-10329378-B2 | Graphene nanoribbons with controlled zig-zag edge and cove edge configuration | ZC3HAV1L, ZC3HAV1, ZYX | CA2 4550/4885LPL 2282/4885LIPG 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.